Interest in the role of FZD9 in the lung was initiated by the discovery that FZD9 and Wnt7a induced non-canonical and tumor suppressive signaling in NSCLC cells, in contrast with studies in osteosarcoma and hepatocellular carcinoma (3, 7, 32). This evidence concerns the gene FZD9 and hepatocellular carcinoma.